Bionano Genomics (BNGO) Depreciation & Amortization (CF) (2017 - 2026)

Bionano Genomics' Depreciation & Amortization (CF) history runs 10 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 5.09% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $8.2 million (down 12.62% YoY), while the FY2025 annual figure was $9.5 million, down 32.06% from the prior year.
• Depreciation & Amortization (CF) came in at $2.3 million for Q1 2026 at Bionano Genomics, down from $2.3 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $3.6 million in Q3 2023 to a low of $1.8 million in Q3 2025.
• A 5-year average of $2.6 million and a median of $2.4 million in 2022 frame the typical range for Depreciation & Amortization (CF).
• Across the five-year window, Depreciation & Amortization (CF) soared 393.3% in 2022 and tumbled 36.74% in 2024, its largest moves.
• Bionano Genomics' Depreciation & Amortization (CF) stood at $2.8 million in 2022, then soared by 30.01% to $3.6 million in 2023, then plunged by 33.31% to $2.4 million in 2024, then declined by 2.54% to $2.3 million in 2025, then declined by 1.16% to $2.3 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $2.3 million, $2.3 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison